Page last updated: 2024-10-30

lomustine and Anal Cancer

lomustine has been researched along with Anal Cancer in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Metastatic anal cancer is a rare disease in the Western hemisphere and current treatment modalities are not effective."2.72Phase II study of mitomycin-C, adriamycin, cisplatin (MAP) and Bleomycin-CCNU in patients with advanced cancer of the anal canal: An eastern cooperative oncology group study E7282. ( Catalano, PJ; Hahn, RG; Haller, D; Harris, J; Jhawer, M; Lefkopoulou, M; Mani, S, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jhawer, M1
Mani, S1
Lefkopoulou, M1
Hahn, RG1
Harris, J1
Catalano, PJ1
Haller, D1

Trials

1 trial available for lomustine and Anal Cancer

ArticleYear
Phase II study of mitomycin-C, adriamycin, cisplatin (MAP) and Bleomycin-CCNU in patients with advanced cancer of the anal canal: An eastern cooperative oncology group study E7282.
    Investigational new drugs, 2006, Volume: 24, Issue:5

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Bleomycin; Ci

2006